NewAge Publishes Major New Discovery on Blocking Spike Proteins From Binding to Human Cells
Retrieved on:
Donnerstag, Oktober 7, 2021
Company, Forward-looking statement, Â, Natural killer T cell, Functional food, Biology, Conference, Iridoid, COVID-19, Food science, US, Cell, Oxidative stress, GLOBE, NK, Industry, Securities Exchange Act of 1934, Antioxidant, U.S. Securities and Exchange Commission, Health, Center for Open Science, FCC, D2C, ELISA, Brand Partners, Nature, Securities Act of 1933, International Conference on Information Systems Security and Privacy, Security (finance), Coronavirus, National Food Security Act, 2013, IL2, Morinda, Inc., Medicine, NIH, Partnership, Science, Newage, Risk, Research, Technology, Center, Pharmaceutical industry
NewAge has discovered what it believes to be breakthrough science in the pursuit of health and the strengthening of peoples immunity.
Key Points:
- NewAge has discovered what it believes to be breakthrough science in the pursuit of health and the strengthening of peoples immunity.
- The conference hosted experts in medicine and biology and industry to discuss the usage of bioactive compoundsfor immune support and health.
- We have now been able to measure the ability of NONI and its major phytonutrients to block the binding of the spike proteins to cellular membranes.
- Using enzyme-linked immunosorbent assays (ELISA) to detect the competitive inhibition of spike protein to Angiotensin II Receptors (ACE-2) binding by NONI, NewAge scientists uncovered that NONI inhibited the ability of the spike proteins to bind ACE-2 by approximately 70%.